ICOTF - Satellos Bioscience GAAP EPS of -C$0.06 May, 31 2022 07:53 AM Ico Therapeutics Inc Satellos Bioscience press release (OTC:ICOTF): Q1 GAAP EPS of -C$0.06. Cash and cash equivalents of C$2,775,494 as at March 31, 2022. For further details see: Satellos Bioscience GAAP EPS of -C$0.06